Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide vs Albumin + Furosemide in Critically Ill Patients
NCT07417969Recruiting
- Sponsor
- Jose J. Zaragoza
- Start
- Jun 2025
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of albumin (human) in Fluid overload (2 arms), sponsored by Jose J. Zaragoza. Primary endpoint: Urine output at 2 hours. Started Jun 2025; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
Fluid overload
Beyond the preview
Go deeper on NCT07417969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07417969.